Landmark proton therapy trial shows 90.9% five-year survival for oropharyngeal cancer vs. 81% with traditional radiation. Precision targeting reduces harmful exposure to healthy tissue, reshaping cancer treatment infrastructure. #ProtonTherapy #Oncology

---

Landmark study shows proton therapy achieves 90.9% five-year survival vs. 81% for traditional radiation in oropharyngeal cancer. The clinical evidence is reshaping cancer treatment infrastructure investments. #ProtonTherapy #Oncology